E
Allurion Technologies Inc. ALUR
$2.77 -$0.0149-0.54% NYSE
Recommendation
Prev Close
$2.77
Volume
21,316
Avg Vol (90D)
298,481
Market Cap
$20.62M
Dividend & Yield
--
52-Week Range
$2.15 - $22.59
P/E (TTM)
--
EPS (TTM)
-$12.51
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Flora Growth Corp. (FLGC) Reports Q2 Loss, Tops Revenue Estimates
8/1/2025 - Zacks Investment Research
Zynex Inc. (ZYXI) Reports Q2 Loss, Misses Revenue Estimates
7/31/2025 - Zacks Investment Research
Allurion Technologies (ALUR) Reports Positive Long-Term Weight Loss Outcomes ALUR Stock News
7/22/2025 - GuruFocus
Allurion Announces New Publications on Long-Term Weight Loss Results with the Allurion Program
7/22/2025 - GuruFocus
Allurion Announces New Publications on Long-Term Weight Loss Results with the Allurion Program
7/22/2025 - Business Wire
Allurion Technologies (NYSE:ALUR) Shares Up 10.5% - Here's What Happened
7/16/2025 - Ticker Report
Allurion Announces Strategic Distribution Partnership with Minogue Medical in Canada to Pioneer ...
7/9/2025 - GuruFocus
Allurion Technologies (ALUR) Forms Strategic Canadian Partnership ALUR Stock News
7/9/2025 - GuruFocus
Allurion Technologies announces distribution partnership with Minogue
7/9/2025 - TipRanks Financial Blog
Allurion Technologies announces distribution partnership with Minogue
7/9/2025 - The Fly
Allurion Announces Strategic Distribution Partnership with Minogue Medical in Canada to Pioneer New Approach Focused on Metabolically Healthy Weight Loss
7/9/2025 - Business Wire
Allurion Announces Submission of PMA to FDA and Additional Analyses From Pivotal AUDACITY Study ...
7/7/2025 - GuruFocus
Allurion Technologies submits PMA to FDA, announces additional AUDACITY data
7/7/2025 - The Fly
Allurion Announces Submission of PMA to FDA and Additional Analyses From Pivotal AUDACITY Study That Meet Both Endpoints
7/7/2025 - Business Wire
Allurion Announces Findings from New Studies on Muscle Mass Maintenance in Nearly 20,000 ...
6/17/2025 - GuruFocus
Allurion Announces Findings from New Studies on Muscle Mass Maintenance in Nearly 20,000 Patients and Four-Year Weight Loss Outcomes at the 2025 Annual Meeting of the ASMBS
6/17/2025 - Business Wire
Allurion to Present at Jefferies Global Healthcare Conference
5/29/2025 - GuruFocus
Allurion to Present at Jefferies Global Healthcare Conference
5/29/2025 - Business Wire
Allurion Technologies Inc. (ALUR) Returns to France with 12.2% Weight Loss, 6.6% Muscle Gain Results
5/27/2025 - Insider Monkey
Allurion Presents Data on Increasing Muscle Mass and Decreasing Fat Mass in Patients Treated ...
5/27/2025 - GuruFocus
Allurion Presents Data on Increasing Muscle Mass and Decreasing Fat Mass in Patients Treated With the Allurion Program
5/27/2025 - Business Wire
Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies
5/22/2025 - Zacks Investment Research
4 Medical Product Stocks to Watch From a Challenging Industry
5/21/2025 - Zacks Investment Research
Allurion Technologies Inc. (NYSE:ALUR) Shares Sold by RTW Investments LP
5/16/2025 - Ticker Report
Yale University's Strategic Exit from Allurion Technologies Inc: A 13F Filing Insight
5/15/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
$28.30M
EBITDA (TTM)
-$43.85M
EBIT (TTM)
-$44.68M
Net Income (TTM)
-$24.36M
Balance Sheet
Total Assets (Q)
$38.41M
Total Debt (Q)
$82.98M
Total Liabilities (Q)
$108.20M
Book Value Per Share (Q)
-$11.70
Cash Flow
Cash from Operations (TTM)
-$43.13M
Cash from Investing (TTM)
-$507.00K
Cash from Financing (TTM)
$34.32M
Net Change in Cash (TTM)
-$9.32M
Filings
Filing Date
Thursday, May 15, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 11 and 15 (est)
Price History
Loading...
Beta
0.89
7-Day Total Return
-5.63%
30-Day Total Return
19.19%
60-Day Total Return
16.18%
90-Day Total Return
-11.09%
Year to Date Total Return
-73.49%
1-Year Total Return
-86.88%
2-Year Total Return
-98.47%
3-Year Total Return
-98.40%
5-Year Total Return
--
52-week Low
Mar 10, 2025 - $2.15
52-week High
Aug 02, 2024 - $22.59
Valuation
Market Cap
$20.62M - Nano Cap
Enterprise Value
$83.19M
Price/Sales (TTM)
0.59
Price/Book (Q)
-0.24
Dividends and Shares
Shares Outstanding
6.02
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.allurion.com
Phone Number
508 647 4000
Address
11 Huron Drive
Natick, MA 01760
Country
United States
Year Founded
--
Business Description
Sector
Consumer Discretionary
Industry
Consumer Services
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less... more
NYSE 08/01/2025 2:38PM Eastern Quotes delayed